Comparison of Combined Spinal-epidural Analgesia Versus Epidural Analgesia for Pain Management During Labor

Overview

The investigators want to compare the safety and efficacy between the combined spinal-epidural analgesia and epidural analgesia during labor.

Full Title of Study: “Comparison of Combined Spinal-epidural Analgesia Versus Epidural Analgesia During Labor”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: November 20, 2018

Detailed Description

Participants who request neuraxial labor analgesia are randomized to receive combined spinal-epidural analgesia or epidural analgesia during labor. The investigators collect the data on the duration of three stages of labor, the mode of delivery, neonatal Apgar scores, VAS scores, modified Bromage scores.

Interventions

  • Procedure: Combined spinal-epidural analgesia
    • Combined spinal-epidural analgesia during labor is a labor analgesia technique which reported maybe associate with a shorter labor duration compared to the traditional epidural labor analgesia.
  • Procedure: Epidural analgesia
    • Epidural analgesia is a well-accepted technique using for pain relief during labor.

Arms, Groups and Cohorts

  • Experimental: Combined spinal-epidural analgesia
    • The combined spinal epidural analgesia technique was used to maintain analgesia for parturients in the combined spinal-epidural analgesia group. First, the investigator injected a dose of 5 ug sufentanil into cerebrospinal fluid. If no adverse effects were observed 10 minutes after the first dose, the parturient then received mixed liquids of 0.075% ropivacaine and 0.2ug/ml sufentanil citrate through a patient-controlled epidural analgesia (PCA) pump, which provided patients themixed solution at 8-10ml/h to optimize their pain relief until the delivery of neonates.
  • Other: Epidural analgesia
    • The epidural analgesia technique was used to maintain analgesia for parturients in the epidural analgesia group, which involved placing a thin catheter through a needle inserted into the epidural space. First, the investigator injected a test dose of 5ml 1% lidocaine through it. If not adverse effects were observed 10 minutes after the test dose, the parturient then received a bolus injection of an initial dose of 8-10 ml mixed liquids of 0.075% ropivacaine and 0.2ug/ml sufentanil citrate. We then connected the catheter with a patient-controlled epidural analgesia (PCA) pump, which provided patients the same mixed solution at 8-10ml/h to optimize their pain relief until the delivery of neonates.

Clinical Trial Outcome Measures

Primary Measures

  • Labor duration
    • Time Frame: At the end of delivery
    • Duration of three stages of labor

Secondary Measures

  • The mode of delivery
    • Time Frame: At the end of delivery
    • Including spontaneous vaginal delivery, vacuum- and forceps-assisted delivery, cesarean delivery
  • 1 minute and 5 minutes Apgar scores
    • Time Frame: 1 min after delivery, 5 min after delivery.
    • Neonatal Apgar scores at the first and fifth minute.The score indicates the infant s’ conditions, including heart rate, breathing, muscle tone, reflex response, color. Each characteristic is given an individual score; two points for each of the five categories if all is completely well; then all scores are totaled. The score is from 0 to 10.
  • Visual Analogue Scores(VAS)
    • Time Frame: At 5min before analgesia; at 5min, 15min, 30min, 1h after the first dose of analgesic drugs; at cervical dilation of 3cm , 6cm and 10cm; at the time of birth of infant; at the time of delivery of placenta.
    • VAS is the most common pain scale for quantification. The score is higher, the patient will be more painful. That will indicate if the analgesia is effective. Visual analog scale (VAS) ranging from 0 to 10 (with 10 representing the worst pain imaginable) to measure the degree of pain for participants.
  • Modified Bromage scores
    • Time Frame: At 5min before analgesia; at 5min, 15min, 30min, 1h after the first dose of analgesic drugs; at the cervical dilation of 3cm , 6cm and 10cm; at the time of birth of infant; at the time of delivery of placenta.
    • The modified Bromage score is the most frequently used measure of motor block. In this scale, the intensity of motor block is assessed by the patient’s ability to move their lower extremities(0: no motor paralysis; 1: inability to raise extended leg, but able to move knee and foot; 2: inability to raise extended leg and to move knee, but able to move foot; 3: inability to raise extended leg or to move knee and foot).

Participating in This Clinical Trial

Inclusion Criteria

  • Healthy women at term (37 to 42 weeks of gestation), vertex presentation, singleton pregnancy who desired vaginal delivery were eligible to participate. Exclusion Criteria:

  • Contraindications to neuraxial techniques such as clinically significant coagulopathy and increased intracranial pressure, and patients with preterm labor, multiple pregnancies, non-vertex presentation, cephalopelvic disproportion and severe obstetric complications

Gender Eligibility: Female

Minimum Age: 15 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Deng Dongrui
  • Collaborator
    • Tongji Hospital
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Deng Dongrui, Professor, Chief doctor – Tongji Hospital
  • Overall Official(s)
    • Haiyi Liu, M.D., Principal Investigator, Tongji Hospital
  • Overall Contact(s)
    • Dongji Han, M.D., +8618971583899, handongjihospital@163.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.